neuro-modulation products, an artificial disc company, a fibrin sealant, a nitinol instrument to be used in conjunction with PMMA that provides a scaffold for VCFx, an annular repair device, a hemostatic agent, a synthetic cartilage, tissue engineering, and a bio-ceramic.
The appealing aspect of these placements is that investors are selectively choosing to invest in peripheral spinal companies. Hopefully this is a good sign for our future and a bad sign for companies that are intent on saturating the industry with additional "me too" products into a zero-sum market. So let's take our hats off to those that were able to be part of a growing trend, and hope that those that entered this industry with the irrational exuberance get the hint, the train left the station and you no longer are on the same track. Please ingratiate our followers and twitters with your thoughts, TSB wants to know what our readers think about some of these technologies?